Literature DB >> 1451739

The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery, but not in saphenous vein.

M Auguet1, S Delaflotte, P E Chabrier, P Braquet.   

Abstract

The effects of big endothelin-1 and endothelin-1 on vascular reactivity were compared in isolated rabbit saphenous artery and vein. The contractile potency of endothelin-1 was three times higher in the vein than in the artery. In contrast, big endothelin-1 was two times more effective in the artery. Phosphoramidon (100 microM), a metalloproteinase inhibitor, antagonised the contractile action of big endothelin-1 in the artery but not in the vein. These data suggest that the biosynthetic pathway leading to the formation of endothelin differs in arterial and venous vessels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451739     DOI: 10.1016/0014-2999(92)94827-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.

Authors:  D M Pollock; T J Opgenorth
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

4.  Modulatory effects of endothelin-1 on purinergic and adrenergic components of sympathetically-mediated contractile activity of rabbit saphenous artery.

Authors:  V N Mutafova-Yambolieva; R G Radomirov
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

5.  Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery.

Authors:  W A Bax; Z Aghai; C L van Tricht; C Wassenaar; P R Saxena
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.